Cargando…

“Ten Commandments” for Conducting Comparative Effectiveness Research Using “Real-World Data”

Detalles Bibliográficos
Autores principales:	Willke, Richard J., Mullins, C. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442902/ https://www.ncbi.nlm.nih.gov/pubmed/22074669 http://dx.doi.org/10.18553/jmcp.2011.17.s9-a.S10

Ejemplares similares

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Infrastructure Requirements for Secondary Data Sources in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Developing a Collaborative Study Protocol for Combining Payer-Specific Data and Clinical Trials for CER
por: Sanchez, Robert J., et al.
Publicado: (2011)

Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting
por: Mullins, C. Daniel
Publicado: (2012)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Something Old, Something New, Something Borrowed"¦Comparative Effectiveness Research: A Policy Perspective
por: Subedi, Prasun, et al.
Publicado: (2011)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”
por: Alemayehu, Demissie, et al.
Publicado: (2011)

The Role of Outcomes Research in Defining and Measuring Value in Benefit Decision
por: Nichol, Michael B.
Publicado: (2006)

Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials
por: Foley, John F., et al.
Publicado: (2013)

Introduction
por: Minkoff, Neil B., et al.
Publicado: (2005)

A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression
por: Malone, Daniel C.
Publicado: (2007)

Assessing Resource Use in Oncology Patients
por: Semroc, Georgette N., et al.
Publicado: (2003)

Usefulness of database Studies as Applied to Managed Care
por: Eisenberg, Steven S.
Publicado: (2005)

Economic and Clinical Impact of Multiple Myeloma to Managed Care
por: Cook, Richard
Publicado: (2008)

Introduction: Multiple Myeloma
por: Cook, Richard
Publicado: (2008)

COPD Clinical Significance of Early Diagnosis
por: Leff, Richard D.
Publicado: (2005)

Evidence Based Health Benefits Management
por: Zabinski, Richard A.
Publicado: (2006)

Antimicrobial Stewardship Programs: How to Start and Steer a Successful Program
por: Drew, Richard H.
Publicado: (2009)

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients
por: Scott, Shane J., et al.
Publicado: (2003)

Value-Based Benefit Design: Using a Predictive Modeling Approach to Improve Compliance
por: Mahoney, John J.
Publicado: (2008)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

Primary Care Physician Perspective on Management of Patients with Depression
por: Ford, Daniel E.
Publicado: (2006)

The Role of Pharmacoeconmic Modeling
por: Malone, Daniel C.
Publicado: (2005)

Introduction
por: kleinke, J.D., et al.
Publicado: (2005)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

AHRQ's Effective Health Care Program: Its Impact on Managed Care
por: Fleming, William K.
Publicado: (2007)

Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Improving Cost-Effectiveness of and Outcomes From Drug Therapy in Patients With Atrial Fibrillation in Managed Care: Role of the Pharmacist
por: Johnson, Samuel G.
Publicado: (2009)

Potential Advantages of Interprofessional Care in Rheumatoid Arthritis
por: Marion, Carrie Engen, et al.
Publicado: (2011)

Core Management Principles in Rheumatoid Arthritis to Help Guide Managed Care Professionals
por: Agarwal, Sandeep K.
Publicado: (2011)

Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals
por: Agarwal, Sandeep K.
Publicado: (2011)

Assessment of Disease Activity and Treatment Outcomes in Rheumatoid Arthritis
por: Farheen, Kiran, et al.
Publicado: (2011)

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

Introduction
por: Rumsfeld, John S.
Publicado: (2006)

Practice Strategies to Improve Compliance and Patient Self-Management
por: Ruetsch, Charles
Publicado: (2010)

Implementing the New Guidelines for Hypertension
por: Carter, Barry L.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_potrjdkcnt2klk1bhclttq44s5